INMB vs MKTX · rev $50.0K vs P/E 13, rev $451.8M
INmune Bio Inc (INMB) versus MarketAxess Holdings Inc (MKTX) — a side-by-side from cached financials, not a winner call.
INmune Bio Inc (INMB) is a biotechnology company listed on US.
MarketAxess Holdings Inc (MKTX) is a capital markets company listed on US.
Latest reported INMB revenue for 2025-09-30 was $50.0K. Net income was -$6.5M. Revenue was up 0.0% from 2025-06-30 to 2025-09-30. INMB currently screens at market cap $33.5M.
Latest reported MKTX revenue for 2026-06-30 was $451.8M. Net income was $146.0M. Revenue was up 93.6% from 2026-03-31 to 2026-06-30. MKTX currently screens at market cap $4.00B and trailing P/E 13.3.
INMB currently screens at market cap $33.5M. MKTX currently screens at market cap $4.00B and trailing P/E 13.3.
Not investment advice. Open the INMB and MKTX stock pages for the full models.
Not investment advice.